Smart Money Is Betting Big In VKTX Options
Smart Money Is Betting Big In VKTX Options
Financial giants have made a conspicuous bullish move on Viking Therapeutics. Our analysis of options history for Viking Therapeutics (NASDAQ:VKTX) revealed 11 unusual trades.
金融巨頭對Viking Therapeutics採取了明顯的看漲舉動。我們對Viking Therapeutics（納斯達克股票代碼：VKTX）期權歷史的分析顯示了11筆不尋常的交易。
Delving into the details, we found 45% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $78,002, and 9 were calls, valued at $1,174,199.
深入研究細節，我們發現45％的交易者看漲，而36％的交易者表現出看跌趨勢。在我們發現的所有交易中，有2筆是看跌期權，價值爲78,002美元，9筆是看漲期權，價值1,174,199美元。
Expected Price Movements
預期的價格走勢
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $68.0 and $130.0 for Viking Therapeutics, spanning the last three months.
在評估了交易量和未平倉合約之後，很明顯，主要的市場走勢者正在關注過去三個月中Viking Therapeutics在68.0美元至130.0美元之間的價格區間。
Insights into Volume & Open Interest
對交易量和未平倉合約的見解
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Viking Therapeutics's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Viking Therapeutics's significant trades, within a strike price range of $68.0 to $130.0, over the past month.
檢查交易量和未平倉合約爲股票研究提供了至關重要的見解。這些信息是衡量Viking Therapeutics期權在特定行使價下的流動性和利息水平的關鍵。下面，我們簡要介紹了過去一個月Viking Therapeutics重大交易的看漲期權和未平倉合約的趨勢，行使價區間爲68.0美元至130.0美元。
Viking Therapeutics Option Volume And Open Interest Over Last 30 Days
Viking Therapeutics 過去 30 天的期權交易量和未平倉合約
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 08/16/24 | $10.4 | $9.6 | $9.7 | $80.00 | $582.0K | 419 | 7 |
| VKTX | CALL | TRADE | BULLISH | 06/21/24 | $6.5 | $4.5 | $6.5 | $75.00 | $110.5K | 2.6K | 184 |
| VKTX | CALL | SWEEP | NEUTRAL | 06/21/24 | $6.3 | $6.0 | $6.3 | $75.00 | $107.1K | 2.6K | 355 |
| VKTX | CALL | TRADE | BEARISH | 06/21/24 | $5.2 | $4.9 | $4.9 | $80.00 | $83.3K | 2.2K | 214 |
| VKTX | CALL | TRADE | BULLISH | 06/21/24 | $6.5 | $6.0 | $6.4 | $75.00 | $81.2K | 2.6K | 483 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 打電話 | 貿易 | 粗魯的 | 08/16/24 | 10.4 美元 | 9.6 美元 | 9.7 美元 | 80.00 美元 | 582.0 萬美元 | 419 | 7 |
| VKTX | 打電話 | 貿易 | 看漲 | 06/21/24 | 6.5 美元 | 4.5 美元 | 6.5 美元 | 75.00 美元 | 110.5 萬美元 | 2.6K | 184 |
| VKTX | 打電話 | 掃 | 中立 | 06/21/24 | 6.3 美元 | 6.0 美元 | 6.3 美元 | 75.00 美元 | 107.1 萬美元 | 2.6K | 355 |
| VKTX | 打電話 | 貿易 | 粗魯的 | 06/21/24 | 5.2 美元 | 4.9 美元 | 4.9 美元 | 80.00 美元 | 83.3 萬美元 | 2.2K | 214 |
| VKTX | 打電話 | 貿易 | 看漲 | 06/21/24 | 6.5 美元 | 6.0 美元 | 6.4 美元 | 75.00 美元 | 81.2 萬美元 | 2.6K | 483 |
About Viking Therapeutics
關於維京療法
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家醫療保健服務提供商。該公司專門從事以代謝和內分泌失調爲重點的生物藥品開發領域。該公司的臨床項目管道包括 VK2809、VK5211、VK0214 產品。VK2809 和 VK0214 是可口服的甲狀腺激素受體 β 的組織和受體亞型選擇性激動劑。VK5211 是一種口服的非甾體選擇性雄激素受體調節劑。
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
在分析了與Viking Therapeutics相關的期權活動之後，我們將轉向仔細研究公司自身的業績。
Viking Therapeutics's Current Market Status
Viking Therapeutics的當前市場狀況
- With a trading volume of 1,399,686, the price of VKTX is down by -0.64%, reaching $68.62.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 68 days from now.
- VKTX的交易量爲1,399,686美元，下跌了-0.64％，至68.62美元。
- 當前的RSI值表明該股可能已接近超買。
- 下一份收益報告定於即日起68天后發佈。
Expert Opinions on Viking Therapeutics
關於維京療法的專家意見
3 market experts have recently issued ratings for this stock, with a consensus target price of $108.66666666666667.
3位市場專家最近發佈了該股的評級，共識目標價爲108.66666666666667美元。
- An analyst from HC Wainwright & Co. downgraded its action to Buy with a price target of $90.
- Reflecting concerns, an analyst from Truist Securities lowers its rating to Buy with a new price target of $120.
- Showing optimism, an analyst from Raymond James upgrades its rating to Strong Buy with a revised price target of $116.
- HC Wainwright & Co. 的一位分析師將其評級下調至買入，目標股價爲90美元。
- 出於擔憂，Truist Securities的一位分析師將其評級下調至買入，新的目標股價爲120美元。
- 雷蒙德·詹姆斯的一位分析師表現出樂觀的態度，將其評級上調至強勢買入，目標股價爲116美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Viking Therapeutics options trades with real-time alerts from Benzinga Pro.
期權交易具有更高的風險和潛在的回報。精明的交易者通過不斷自我教育、調整策略、監控多個指標以及密切關注市場走勢來管理這些風險。藉助Benzinga Pro的實時提醒，隨時了解最新的Viking Therapeutics期權交易。